Your browser doesn't support javascript.
loading
Guanidinoacetic acid deficiency: a new entity in clinical medicine?
Ostojic, Sergej M; Ratgeber, Laszlo; Olah, Andras; Betlehem, Jozsef; Acs, Pongras.
Afiliação
  • Ostojic SM; FSPE Applied Bioenergetics Lab, University of Novi Sad, Novi Sad, Serbia.
  • Ratgeber L; Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
  • Olah A; Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
  • Betlehem J; Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
  • Acs P; Faculty of Health Sciences, University of Pecs, Pecs, Hungary.
Int J Med Sci ; 17(16): 2544-2550, 2020.
Article em En | MEDLINE | ID: mdl-33029096
ABSTRACT
Guanidinoacetic acid (GAA, also known as glycocyamine or betacyamine) is a naturally-occurring derivative of glycine and a direct metabolic precursor of creatine, a key player in high-phosphate cellular bioenergetics. GAA is found in human serum and urine, with circulating GAA likely reflects an equilibrium between its endogenous production and utilization/excretion. GAA deficiency (as indicated by low serum GAA) has been reported in various conditions yet this intriguing clinical entity appears to be poorly characterized as yet, either as a primary deficit or a sequel of secondary disease. This minireview article summarizes the inherited and acquired disorders with apparent GAA deficiency and discusses a possible relevance of GAA shortfall in clinical medicine.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicina / Doenças Metabólicas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicina / Doenças Metabólicas Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article